Details of the Drug

General Information of Drug (ID: DM7CHZ2)

Drug Name
TTC-352
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Phase 1 [1]
Metastatic melanoma 2E2Z Phase 1 [2]
Cross-matching ID
PubChem CID
74222430
TTD ID
D0NZ3C

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Estrogen receptor (ESR) TTZAYWL ESR1_HUMAN Agonist [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT03201913) Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy. U.S. National Institutes of Health.